Navigation Links
Vermillion Sets First Quarter 2013 Conference Call for Wednesday, May 15, 2013
Date:5/1/2013

AUSTIN, Texas, May 1, 2013 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a molecular diagnostics company focused on gynecologic cancers and women's health, will hold a conference call on Wednesday, May 15, 2013, at 4:30 p.m. Eastern time to discuss results for the first quarter ended March 31, 2013. Financial results will be issued in a press release prior to the call.

Vermillion's President and CEO Thomas McLain will host the call, followed by a question and answer period.

Date: Wednesday, May 15, 2013
Time: 4:30 p.m. Eastern time (3:30 p.m. Central time)
Dial-In number: 1-800-709-0218
International: 1-212-231-2915
Conference ID: 21656230
Webcast: http://www.media-server.com/m/p/mo7xofgw

The conference call will be webcast live and available for replay via the investor section of the company's website at www.vermillion.com.

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Liolios Group at 1-949-574-3860.

A replay of the call will be available approximately two hours after the call through May 29, 2013.

Toll-free replay number: 1-800-633-8284
International replay number: 1-402-977-9140
Replay ID: 21656230

About Vermillion

Vermillion, Inc. (NASDAQ: VRML) is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, vascular medicine and women's health. Additional information about Vermillion can be found at www.vermillion.com.

Investor Relations Contact:
Liolios Group, Inc.
Ron Both
Tel 1-949-574-3860
vrml@liolios.com


'/>"/>
SOURCE Vermillion, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET
2. Vermillion Announces CEO Succession Plan
3. Vermillion PAD Intended Use Study Presented at Society for Vascular Medicine 23rd Annual Scientific Sessions
4. Vermillion Announces Positive Top-Line Results from the OVA500 Multi-Center Study Led by UC Irvine
5. Vermillion Reports Second Quarter 2012 Results
6. Vermillion to Present at the 2012 Gateway Conference on September 6
7. Vermillion Sets Third Quarter 2012 Conference Call for Monday, November 12, 2012 at 4:30 p.m. ET
8. Vermillion Reports Third Quarter 2012 Results
9. Delaware Court of Chancery Dismisses Vermillion Dissident Shareholder Suit with Prejudice
10. Vermillion Appoints Bruce A. Huebner as Interim Chief Executive Officer
11. Gynecologic Oncology Publishes New Clinical Study Showing Positive Performance of OVA1, Vermillions Ovarian Cancer Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2020)... , ... July 22, 2020 , ... ... technology, is proud to announce the addition of Moderna to its growing customer ... rely on its technology for trial disclosure management, patient engagement and study recruitment. ...
(Date:7/18/2020)... (PRWEB) , ... July 17, 2020 , ... ... of Consultation-Liaison Psychiatry uses case scenarios to illustrate how implicit bias among psychiatrists ... care provided to sexual and gender minority people. The Perspective was authored by ...
(Date:7/10/2020)... (PRWEB) , ... July 09, 2020 , ... The team ... final touches to their completely redesigned website. The new site offers a multitude of ... wealth of free downloadable information available with easy to navigate menus which will allow ...
Breaking Medicine Technology:
(Date:8/3/2020)... ... August 03, 2020 , ... WorkBook6 – ... newest product, CoverageCoach. The site provides a simple and efficient way for Americans ... company sees CoverageCoach as an important expansion for the insurance marketing ecosystem, and ...
(Date:7/31/2020)... , ... July 31, 2020 , ... ... Meridian Clinical Research’s internal medicine site in Savannah, GA. Visitors included ... OWS. , In May, the federal government announced the OWS program to accelerate ...
(Date:7/31/2020)... ... 31, 2020 , ... National Association of Chain Drug Stores ... the nation’s ongoing preparations for the eventual deployment of COVID-19 vaccines: , “By ... and essential component of vaccine deployment. They will need to be part of ...
(Date:7/22/2020)... ... July 22, 2020 , ... With Covid-19 and the racial ... has changed, and there’s no going back. In confronting our discomfort during 2020, ... temporarily manage emotional struggles, healing is the approach we should strive for. Lasting ...
(Date:7/22/2020)... (PRWEB) , ... July 22, 2020 , ... ... announced the launch of its new Data Curation as a Service (DCaaS) solution ... case modules focus on specific clinical data curation parameters and are custom tailored ...
Breaking Medicine News(10 mins):